AC
CRBU icon

AXQ Capital’s Caribou Biosciences CRBU Stock Holding History

AXQ Capital’s Portfolio CRBU Stock Details CRBU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$28.5K Buy
+15,000
New +$25.7K ﹤0.01% 954
2024
Q2 		– Sell
-13,750
Closed -$70.7K – 498
2024
Q1 		$70.7K Buy
+13,750
New +$84.8K 0.02% 591

Other funds holding CRBU

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

AXQ Capital's CRBU Position: Q1 2026 in Review

AXQ Capital opened a new position in Caribou Biosciences (CRBU) in Q1 2026: 15,000 shares worth $28.5K. The stake represents ﹤0.01% of the portfolio and ranks #954 among its holdings. This is a return to the name: AXQ Capital previously reported a position in CRBU as recently as Q1 2024.

AXQ Capital first reported a position in CRBU in Q1 2024 and has held it in 2 quarters since. The position peaked at $70.7K in Q1 2024. 137 funds tracked by Wall St. Rank hold CRBU as of Q1 2026.

  • AXQ Capital held 15,000 shares of Caribou Biosciences worth $28.5K as of Q1 2026.
  • Caribou Biosciences was a new AXQ Capital position in Q1 2026.
  • Caribou Biosciences made up ﹤0.01% of AXQ Capital's portfolio in Q1 2026, its #954 holding.
  • AXQ Capital first reported a position in Caribou Biosciences in Q1 2024 and has held it in 2 quarters since.
  • AXQ Capital's Caribou Biosciences position peaked at $70.7K in Q1 2024.
  • 137 funds tracked by Wall St. Rank held Caribou Biosciences as of Q1 2026.

Based on AXQ Capital's 13F filing for Q1 2026, filed 13 May 2026.